Expression and Effects of FUS/Sfrp5/Wnt5 in Atherosclerosis Development.

IF 1.1 4区 医学 Q4 MEDICAL LABORATORY TECHNOLOGY
Xiaogao Wang, Hui Wang, Ran Lu, Shiyuan Chen, Yong Gao, Chaowen Yu
{"title":"Expression and Effects of FUS/Sfrp5/Wnt5 in Atherosclerosis Development.","authors":"Xiaogao Wang, Hui Wang, Ran Lu, Shiyuan Chen, Yong Gao, Chaowen Yu","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Atherosclerosis (AS) contributes significantly to the development of cardiovascular disease. Despite recent advances in medical treatment, the outcomes for patients with AS are still unsatisfactory. This study aims to enhance our understanding of AS and pave the way for the development of more effective therapeutic approaches to improve patient outcomes and ultimately reduce the burden of this devastating condition.</p><p><strong>Methods: </strong>An AS cell model was established using oxidized low-density lipoprotein (OX-LDL) administration to human vascular smooth muscle cells (HVSMCs), followed by injection with oe-NC, oe-FUS, oe-Sfrp5, or oe-FUS+ oe-Sfrp5. Western blot, Transwell assay, CCK8 assay, Oil Red O staining assay, and ELISA were used to elucidate the mechanisms of the FUS/Sfrp5/Wnt5 pathway in our model of AS.</p><p><strong>Results: </strong>In this study, both FUS and Sfrp5 inhibited Wnt5a expression. In addition, FUS inhibited lipid droplet formation and migration capacity of OX-LDL-induced HVSMCs, and FUS and Sfrp5 may have a synergistic effect in controlling Wnt5a in AS. These results highlight the potential therapeutic value of targeting the FUS and Sfrp5 pathway to control AS progression.</p><p><strong>Conclusion: </strong>The findings suggest that FUS and Sfrp5 may have a synergistic effect in controlling Wnt5a in AS.</p>","PeriodicalId":8228,"journal":{"name":"Annals of clinical and laboratory science","volume":"55 2","pages":"240-246"},"PeriodicalIF":1.1000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of clinical and laboratory science","FirstCategoryId":"3","ListUrlMain":"","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Atherosclerosis (AS) contributes significantly to the development of cardiovascular disease. Despite recent advances in medical treatment, the outcomes for patients with AS are still unsatisfactory. This study aims to enhance our understanding of AS and pave the way for the development of more effective therapeutic approaches to improve patient outcomes and ultimately reduce the burden of this devastating condition.

Methods: An AS cell model was established using oxidized low-density lipoprotein (OX-LDL) administration to human vascular smooth muscle cells (HVSMCs), followed by injection with oe-NC, oe-FUS, oe-Sfrp5, or oe-FUS+ oe-Sfrp5. Western blot, Transwell assay, CCK8 assay, Oil Red O staining assay, and ELISA were used to elucidate the mechanisms of the FUS/Sfrp5/Wnt5 pathway in our model of AS.

Results: In this study, both FUS and Sfrp5 inhibited Wnt5a expression. In addition, FUS inhibited lipid droplet formation and migration capacity of OX-LDL-induced HVSMCs, and FUS and Sfrp5 may have a synergistic effect in controlling Wnt5a in AS. These results highlight the potential therapeutic value of targeting the FUS and Sfrp5 pathway to control AS progression.

Conclusion: The findings suggest that FUS and Sfrp5 may have a synergistic effect in controlling Wnt5a in AS.

FUS/ strp5 /Wnt5在动脉粥样硬化中的表达及作用
目的:动脉粥样硬化(AS)在心血管疾病的发生发展中起着重要作用。尽管最近医学治疗取得了进展,但AS患者的预后仍然令人不满意。这项研究旨在增强我们对AS的理解,并为开发更有效的治疗方法铺平道路,以改善患者的预后,并最终减轻这种毁灭性疾病的负担。方法:将氧化低密度脂蛋白(OX-LDL)注入人血管平滑肌细胞(HVSMCs),建立AS细胞模型,然后注射oe-NC、oe-FUS、oe-Sfrp5或oe-FUS+ oe-Sfrp5。采用Western blot、Transwell法、CCK8法、Oil Red O染色法和ELISA法,对FUS/ strp5 /Wnt5通路在AS模型中的作用机制进行了分析。结果:在本研究中,FUS和strp5均抑制Wnt5a的表达。此外,FUS抑制ox - ldl诱导的HVSMCs的脂滴形成和迁移能力,FUS和strp5可能在控制AS中的Wnt5a中具有协同作用。这些结果强调了靶向FUS和strp5通路控制AS进展的潜在治疗价值。结论:研究结果提示FUS和strp5在控制AS中Wnt5a可能具有协同作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Annals of clinical and laboratory science
Annals of clinical and laboratory science 医学-医学实验技术
CiteScore
1.60
自引率
0.00%
发文量
112
审稿时长
6-12 weeks
期刊介绍: The Annals of Clinical & Laboratory Science welcomes manuscripts that report research in clinical science, including pathology, clinical chemistry, biotechnology, molecular biology, cytogenetics, microbiology, immunology, hematology, transfusion medicine, organ and tissue transplantation, therapeutics, toxicology, and clinical informatics.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信